Ellevest Inc’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,374
| Closed | -$294K | – | 434 |
|
|
2025
Q3 | $294K | Sell |
4,374
-1,343
| -23% | -$106K | 0.04% | 336 |
|
|
2025
Q2 | $499K | Sell |
5,717
-377
| -6% | -$29.6K | 0.08% | 195 |
|
|
2025
Q1 | $416K | Buy |
6,094
+954
| +19% | +$77.8K | 0.03% | 222 |
|
|
2024
Q4 | $400K | Buy |
+5,140
| New | +$381K | 0.02% | 247 |
|
|
2024
Q3 | – | Sell |
-4,663
| Closed | -$529K | – | 434 |
|
|
2024
Q2 | $529K | Sell |
4,663
-187
| -4% | -$23.6K | 0.03% | 199 |
|
|
2024
Q1 | $673K | Buy |
4,850
+245
| +5% | +$30.8K | 0.04% | 153 |
|
|
2023
Q4 | $571K | Buy |
4,605
+154
| +3% | +$15.7K | 0.04% | 159 |
|
|
2023
Q3 | $415K | Buy |
4,451
+32
| +0.7% | +$3.61K | 0.03% | 191 |
|
|
2023
Q2 | $568K | Buy |
4,419
+753
| +21% | +$91.1K | 0.04% | 132 |
|
|
2023
Q1 | $426K | Buy |
3,666
+168
| +5% | +$18.8K | 0.03% | 169 |
|
|
2022
Q4 | $396K | Sell |
3,498
-181
| -5% | -$19.9K | 0.03% | 171 |
|
|
2022
Q3 | $296K | Sell |
3,679
-206
| -5% | -$17.4K | 0.03% | 184 |
|
|
2022
Q2 | $290K | Sell |
3,885
-339
| -8% | -$30.9K | 0.03% | 197 |
|
|
2022
Q1 | $540K | Buy |
4,224
+2,400
| +132% | +$263K | 0.05% | 105 |
|
|
2021
Q4 | $245K | Buy |
1,824
+1,768
| +3,157% | +$254K | 0.02% | 257 |
|
|
2021
Q3 | $8K | Sell |
56
-48
| -46% | -$6.05K | ﹤0.01% | 861 |
|
|
2021
Q2 | $11K | Sell |
104
-316
| -75% | -$30.3K | ﹤0.01% | 739 |
|
|
2021
Q1 | $38K | Hold |
420
| – | – | ﹤0.01% | 534 |
|
|
2020
Q4 | $39K | Sell |
420
-84
| -17% | -$7.5K | 0.01% | 514 |
|
|
2020
Q3 | $52K | Buy |
504
+8
| +2% | +$836 | 0.01% | 363 |
|
|
2020
Q2 | $50K | Buy |
496
+4
| +0.8% | +$358 | 0.01% | 356 |
|
|
2020
Q1 | $33K | Hold |
492
| – | – | 0.01% | 318 |
|
|
2019
Q4 | $27K | Buy |
492
+464
| +1,657% | +$22K | 0.01% | 356 |
|
|
2019
Q3 | $1K | Buy |
28
+8
| +40% | +$311 | ﹤0.01% | 385 |
|
|
2019
Q2 | $1K | Sell |
20
-16
| -44% | -$503 | ﹤0.01% | 364 |
|
|
2019
Q1 | $1K | Hold |
36
| – | – | ﹤0.01% | 312 |
|
|
2018
Q4 | $1K | Buy |
+36
| New | +$1.14K | ﹤0.01% | 479 |
|
Other funds holding DXCM
Ellevest Inc's DXCM Position: Q4 2025 in Review
Ellevest Inc sold out of DexCom (DXCM) in Q4 2025, closing a stake of 4,374 shares — an estimated $294K sold.
Ellevest Inc first reported a position in DXCM in Q4 2018 and held it in 27 quarters. The position peaked at $673K in Q1 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.
- Ellevest Inc reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
- Ellevest Inc sold 4,374 DexCom shares in Q4 2025, an estimated $294K.
- Ellevest Inc first reported a position in DexCom in Q4 2018 and held it in 27 quarters.
- Ellevest Inc's DexCom position peaked at $673K in Q1 2024.
- 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.
Based on Ellevest Inc's 13F filing for Q4 2025, filed 10 Feb 2026.